SE0003125D0 - Modified polymers - Google Patents

Modified polymers

Info

Publication number
SE0003125D0
SE0003125D0 SE0003125A SE0003125A SE0003125D0 SE 0003125 D0 SE0003125 D0 SE 0003125D0 SE 0003125 A SE0003125 A SE 0003125A SE 0003125 A SE0003125 A SE 0003125A SE 0003125 D0 SE0003125 D0 SE 0003125D0
Authority
SE
Sweden
Prior art keywords
water
soluble
modified
polysaccharide
soluble polysaccharide
Prior art date
Application number
SE0003125A
Other languages
English (en)
Inventor
Marianne Eklund
Jan-Eric Loefroth
Urban Skantze
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0003125A priority Critical patent/SE0003125D0/sv
Publication of SE0003125D0 publication Critical patent/SE0003125D0/sv
Priority to ES01963156T priority patent/ES2272527T3/es
Priority to JP2002524475A priority patent/JP2004508322A/ja
Priority to EP01963156A priority patent/EP1322293B1/en
Priority to US10/362,261 priority patent/US20040022850A1/en
Priority to AT01963156T priority patent/ATE340564T1/de
Priority to PCT/GB2001/003861 priority patent/WO2002019990A1/en
Priority to DE60123447T priority patent/DE60123447T2/de
Priority to AU2001284189A priority patent/AU2001284189A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
SE0003125A 2000-09-05 2000-09-05 Modified polymers SE0003125D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0003125A SE0003125D0 (sv) 2000-09-05 2000-09-05 Modified polymers
ES01963156T ES2272527T3 (es) 2000-09-05 2001-08-30 Formulacion de liberacion modificada.
JP2002524475A JP2004508322A (ja) 2000-09-05 2001-08-30 放出修飾製剤
EP01963156A EP1322293B1 (en) 2000-09-05 2001-08-30 Modified release formulation
US10/362,261 US20040022850A1 (en) 2000-09-05 2001-08-30 Modified release formulation
AT01963156T ATE340564T1 (de) 2000-09-05 2001-08-30 Arzneimittel mit verzögerter wirkstoffabgabe
PCT/GB2001/003861 WO2002019990A1 (en) 2000-09-05 2001-08-30 Modified release formulation
DE60123447T DE60123447T2 (de) 2000-09-05 2001-08-30 Arzneimittel mit verzögerter wirkstoffabgabe
AU2001284189A AU2001284189A1 (en) 2000-09-05 2001-08-30 Modified release formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0003125A SE0003125D0 (sv) 2000-09-05 2000-09-05 Modified polymers

Publications (1)

Publication Number Publication Date
SE0003125D0 true SE0003125D0 (sv) 2000-09-05

Family

ID=20280889

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0003125A SE0003125D0 (sv) 2000-09-05 2000-09-05 Modified polymers

Country Status (9)

Country Link
US (1) US20040022850A1 (sv)
EP (1) EP1322293B1 (sv)
JP (1) JP2004508322A (sv)
AT (1) ATE340564T1 (sv)
AU (1) AU2001284189A1 (sv)
DE (1) DE60123447T2 (sv)
ES (1) ES2272527T3 (sv)
SE (1) SE0003125D0 (sv)
WO (1) WO2002019990A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
MX2007010660A (es) 2005-03-02 2007-11-07 Hercules Inc Hidroxietilcelulosa de baja sustitucion soluble en agua, derivados de la misma, proceso de fabricacion, y usos de la misma.
JP5866358B2 (ja) * 2010-07-28 2016-02-17 ダウ グローバル テクノロジーズ エルエルシー 剤形からの活性含有成分の放出の制御方法
US20190263938A1 (en) * 2016-09-29 2019-08-29 Sumitomo Seika Chemicals Co., Ltd. Method for producing water-soluble hydroxyethyl cellulose
EP3768378A4 (en) 2018-03-22 2021-11-17 InCarda Therapeutics, Inc. INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
JPS5163927A (en) * 1974-11-28 1976-06-02 Shinetsu Chemical Co Ketsugoseiryokonajozaihokaizaino seizohoho
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
US4024335A (en) * 1976-05-04 1977-05-17 Union Carbide Corporation Homogeneous hydroxy-alkylation of cellulose
AR241633A1 (es) * 1982-12-30 1992-10-30 Goemar Lab Sa Procedimiento para la preparacion de un extracto fisiologico de algas o plantas.
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4851233A (en) * 1986-10-06 1989-07-25 Warner-Lambert Company Sustained release formulations
FR2634397B2 (fr) * 1986-12-31 1991-04-19 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules
BR8806902A (pt) * 1987-04-16 1989-10-31 Christian Bindschaedler Processo para preparacao de um po de polimero insoluvel em agua que pode ser redispersado em uma fase liquida,po resultante e sua utilizacao
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5073380A (en) * 1987-07-27 1991-12-17 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5066793A (en) * 1987-10-26 1991-11-19 Ciba-Geigy Corporation Finely particulate cellulose esters of aromatic or aromatic-aliphatic carboxylic acids, process for their preparation, and the use thereof
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
AT395724B (de) * 1990-12-07 1993-02-25 Chemiefaser Lenzing Ag Verfahren zur herstellung von celluloseformkoerpern
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
DE69332291T2 (de) * 1992-10-16 2003-07-31 Nippon Shinyaku Co Ltd Verfahren zur herstellung von wachsmatrizes
WO1994015643A1 (en) * 1992-12-30 1994-07-21 Fmc Corporation Readily available konjac glucomannan sustained release excipient
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
EP0804169A4 (en) * 1994-12-01 1998-08-19 Cibus Pharmaceutical Inc NSAID ADMINISTRATION USING A POWDERED HYDROCOLLOID GUM MACHINABLE FROM HIGHER PLANTS
MX9704043A (es) * 1994-12-01 1998-02-28 Cibus Pharmaceuticals Inc Surtido de farmaco de liberacion sostenida empleando una goma de hidrocoloide en polvo obtenible a partir de plantas superiores.
US6063402A (en) * 1995-06-07 2000-05-16 Venture Lending, A Division Of Cupertino National Bank Purified galactomannan as an improved pharmaceutical excipient
US6652882B1 (en) * 1997-10-06 2003-11-25 Intellipharmaceutics Corp Controlled release formulation containing bupropion

Also Published As

Publication number Publication date
EP1322293B1 (en) 2006-09-27
EP1322293A1 (en) 2003-07-02
JP2004508322A (ja) 2004-03-18
DE60123447D1 (de) 2006-11-09
AU2001284189A1 (en) 2002-03-22
ES2272527T3 (es) 2007-05-01
US20040022850A1 (en) 2004-02-05
WO2002019990A1 (en) 2002-03-14
ATE340564T1 (de) 2006-10-15
DE60123447T2 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
NZ527585A (en) Tablets quickly disintegrated in oral cavity
CY1105515T1 (el) Μεθοδος παρασκευης στερεων διασπορων
HRP20070432A2 (en) Gastroresistant pharmaceutical formulations containing rifaximin
HUP0004924A2 (hu) Ciklodextrineket tartalmazó gyógyászati készítmények
NO20070719L (no) Tablettformulering med forlenget frigivelse som inneholder pramipeksol eller et farmasoytisk akseptabelt salt derav, fremgangsmate for fremstilling av den og anvendelse derav
DK1061900T3 (da) Dermale præparater
MXPA05012821A (es) Formulacion farmaceutica que comprende un agente activo insoluble en agua.
MXPA05007163A (es) Derivados polimericos de acido maleamico y sus bioconjugados.
SE9904505D0 (sv) Novel compounds
PL335571A1 (en) Stabilisation of acid-sensitive benzimidazoles by combining them with amino acids and cyclodextrins
HK1038699A1 (en) Aqueous process for manufacturing paroxetine solid dispersions
WO2006007354A3 (en) A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
SE0003125D0 (sv) Modified polymers
DE60017444D1 (de) Pharmazeutische formulierungen auf basis fester dispersionen
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
MD20180043A2 (ro) Procedeu de obţinere a unui conjugat de hialuronidază cu derivaţi ai polietilenpiperazinei şi aplicarea conjugatului obţinut
WO2006034147A3 (en) Compositions and methods for the preparation and administration of poorly water soluble drugs
BR0012735A (pt) Preparação solida, e, processo para produzir preparações
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
BR0112258A (pt) Sistema de entrega de droga para drogas pouco solúveis em água
Wasnik et al. Development and evaluation of buccoadhesive tablet for selegiline hydrochloride based on thiolated polycarbophil
DE50005082D1 (de) Verfahren zu Herstellung von PULVERFÖRMIGEn SOLUBILISATIONSHILFSSTOFFEn FÜR FESTE PHARMAZEUTISCHE DARREICHUNGSFORMEN
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.